Evidence map›Paper›PMID 34662333›Full record

ArticlePLoS medicine2021

Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.

John Stover, Robert Glaubius, Yu Teng, Sherrie Kelly, Tim Brown, Timothy B Hallett, Paul Revill, Till Bärnighausen, Andrew N Phillips, Christopher Fontaine and 7 more

Abstract read
In one paragraph

Article in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

John StoverAvenir Health, Glastonbury, Connecticut, United States of America.ORCID 0000-0001-7236-1989
Robert GlaubiusAvenir Health, Glastonbury, Connecticut, United States of America.ORCID 0000-0002-4936-0264
Yu TengAvenir Health, Glastonbury, Connecticut, United States of America.
Sherrie KellyBurnet Institute, Melbourne, Victoria, Australia.
Tim BrownEast-West Center, Honolulu, Hawaii, United States of America.
Timothy B HallettMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.ORCID 0000-0002-9681-0424
Paul RevillCentre for Health Economics, University of York, York, United Kingdom.ORCID 0000-0001-8632-0600
Till BärnighausenHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-4182-4212
Andrew N PhillipsInstitute for Global Health, University College London, London, United Kingdom.ORCID 0000-0003-2384-4807
Christopher FontaineUNAIDS, Geneva, Switzerland.ORCID 0000-0001-5828-3291
Luisa FrescuraUNAIDS, Geneva, Switzerland.ORCID 0000-0002-2089-7818
Jose Antonio Izazola-LiceaUNAIDS, Geneva, Switzerland.ORCID 0000-0002-3658-2570
Iris SeminiUNAIDS, Geneva, Switzerland.
Peter Godfrey-FaussettUNAIDS, Geneva, Switzerland.ORCID 0000-0002-5929-9524
Paul R De LayConsultant, Washington, DC, United States of America.ORCID 0000-0003-4431-3327
Adèle Schwartz BenzakenAIDS Health Care Foundation, Los Angeles, California, United States of America.ORCID 0000-0002-1656-5749
Peter D GhysUNAIDS, Geneva, Switzerland.

Funding

Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

backgroundUNAIDS has established new program targets for 2025 to achieve the goal of eliminating AIDS as a public health threat by 2030. This study reports on efforts to use mathematical models to estimate the impact of achieving those targets. METHODS AND

findingsWe simulated the impact of achieving the targets at country level using the Goals model, a mathematical simulation model of HIV epidemic dynamics that includes the impact of prevention and treatment interventions. For 77 high-burden countries, we fit the model to surveillance and survey data for 1970 to 2020 and then projected the impact of achieving the targets for the period 2019 to 2030. Results from these 77 countries were extrapolated to produce estimates for 96 others. Goals model results were checked by comparing against projections done with the Optima HIV model and the AIDS Epidemic Model (AEM) for selected countries. We included estimates of the impact of societal enablers (access to justice and law reform, stigma and discrimination elimination, and gender equality) and the impact of Coronavirus Disease 2019 (COVID-19). Results show that achieving the 2025 targets would reduce new annual infections by 83% (71% to 86% across regions) and AIDS-related deaths by 78% (67% to 81% across regions) by 2025 compared to 2010. Lack of progress on societal enablers could endanger these achievements and result in as many as 2.6 million (44%) cumulative additional new HIV infections and 440,000 (54%) more AIDS-related deaths between 2020 and 2030 compared to full achievement of all targets. COVID-19-related disruptions could increase new HIV infections and AIDS-related deaths by 10% in the next 2 years, but targets could still be achieved by 2025. Study limitations include the reliance on self-reports for most data on behaviors, the use of intervention effect sizes from published studies that may overstate intervention impacts outside of controlled study settings, and the use of proxy countries to estimate the impact in countries with fewer than 4,000 annual HIV infections.

conclusionsThe new targets for 2025 build on the progress made since 2010 and represent ambitious short-term goals. Achieving these targets would bring us close to the goals of reducing new HIV infections and AIDS-related deaths by 90% between 2010 and 2030. By 2025, global new infections and AIDS deaths would drop to 4.4 and 3.9 per 100,000 population, and the number of people living with HIV (PLHIV) would be declining. There would be 32 million people on treatment, and they would need continuing support for their lifetime. Incidence for the total global population would be below 0.15% everywhere. The number of PLHIV would start declining by 2023.

Indexed as

Disease EradicationGlobal HealthGoalsModels, BiologicalModels, TheoreticalPublic HealthAcquired Immunodeficiency SyndromeAdolescentAdultCause of DeathCOVID-19EpidemicsFemaleHIV InfectionsHumansIncidence

Identifiers

PMID34662333
PMCPMC8559943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.